Mallah, Narmeen
Zapata-Cachafeiro, Maruxa
Aguirre, Carmelo
Ibarra-García, Eguzkiñe
Palacios–Zabalza, Itziar
Macías García, Fernando
iglesias García, Julio
Piñeiro-Lamas, María
Ibáñez, Luisa
Vidal, Xavier
Vendrell, Lourdes
Martin-Arias, Luis
Gil, María Sáinz
Velasco-González, Verónica
Salgado-Barreira, Ángel
Figueiras, Adolfo
Funding for this research was provided by:
Fondo de Investigación Sanitaria (PI021512, PI021364, PI020661, PI021572, PI021512, PI021364, PI020661, PI021572, PI021512, PI021364, PI020661, PI021572, PI021512, PI021364, PI020661, PI021572)
Department of Health of the Basque Country (03/11092 and 11/111103)
Fundacion vasca de innovacin e investigacin sanitarias (OSIBG19/002 and OSIBG18/105)
Novartis
Pfizer
Dr Esteve
Instituto de Salud Carlos III (PI12/02414)
Galician Regional Authority, Spain (PGIDIT03PXIC20806PN)
Article History
Received: 20 May 2021
Accepted: 23 September 2021
First Online: 7 October 2021
Competing interests
: The authors declare no competing interests.